Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and G-CSF with Busulfan/Fludarabine for Allo-SCT in Myeloid Leukemias
NCT00822770Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2009; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00822770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822770.